Intensified RITA treatment did not increase CDKN1A expression, but increased MDM2 expression (P = 0.01) and activated the TP53 pathway in the xenograft tumor tissue (Figure 4C–4F), which corresponded well with our results for RITA treatment of medulloblastoma cell lines grown in vitro. This evidence concerns the gene MDM2 and neoplasm.